The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain.

BCL6 is a transcriptional repressor that is over-expressed due to chromosomal translocations, or other abnormalities, in ∼40% of diffuse large B-cell lymphoma. BCL6 interacts with co-repressor, SMRT, and this is essential for its role in lymphomas. Peptide or small molecule inhibitors, which prevent...

Description complète

Détails bibliographiques

Auteurs principaux:	Sian E Evans, Benjamin T Goult, Louise Fairall, Andrew G Jamieson, Paul Ko Ferrigno, Robert Ford, John W R Schwabe, Simon D Wagner
Format:	Artigo
Langue:	Inglês
Publié:	Public Library of Science (PLoS) 2014-01-01
Collection:	PLoS ONE
Accès en ligne:	https://doi.org/10.1371/journal.pone.0090889
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!